Condition
Prognostic Stage IIIA Breast Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Prognostic Stage IIIA Breast Cancer AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Prognostic Stage IIIA Breast Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer | Phase 1 | Atlanta, Georgia and 3 other locations | Recruiting | Mar 21, 2024 |
| Using minoxidil to treat hair loss in breast cancer patients on endocrine therapy | Early Phase 1 | Columbus, Ohio | Recruiting | Jun 14, 2022 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations | Phase 2 | Houston, Texas | Recruiting | Sep 16, 2019 |
| A tool to help patients decide on contralateral prophylactic mastectomy for breast cancer | — | Houston, Texas | Recruiting | Sep 29, 2016 |
All recruiting trials (5)
-
Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer
This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.
-
Using minoxidil to treat hair loss in breast cancer patients on endocrine therapy
This study is testing if a hair loss treatment called minoxidil, given either as a foam or a pill, can help women with breast cancer who are losing their hair due to cancer therapy.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations
This study is testing if combining the drugs olaparib with either cediranib or AZD6738 can help women with advanced breast cancer that has BRCA mutations feel better after they’ve already tried other treatments.
-
A tool to help patients decide on contralateral prophylactic mastectomy for breast cancer
This study tests if an online tool can help women newly diagnosed with breast cancer make better choices about having a preventive mastectomy on the other breast.
Related topics
Quick answers
How many Prognostic Stage IIIA Breast Cancer AJCC v8 clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.